The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity
Authors:
- 31 May 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 14 (5) , 647-653
Abstract
Many peptides are synthesised and released from the gastrointestinal tract. Although their roles in the regulation of gastrointestinal function have been known for some time, it has become increasingly evident that they also influence eating behaviour. Peptide YY (PYY) is released postprandially from gastrointestinal L-cells with glucagon-like peptide 1 (GLP-1) and oxynto-modulin. Following peripheral administration of PYY3-36, the circulating form of PYY, to mouse, rat or human there is marked inhibition of food intake. Obese subjects have lower basal fasting PYY levels and have a smaller postprandial rise. However, obesity does not appear to be associated with resistance to PYY (as it is with leptin) and exogenous infusion of PYY3-36 results in a reduction in food intake by 30% in an obese group and 31% in a lean group at a buffet meal. Overall PYY significantly reduced 24-h caloric intake in both obese (16.5%) and lean groups (23.5%). Obesity is the current major cause of premature death in the UK, killing almost 1000 people a week. Worldwide its prevalence is accelerating. The administration of the naturally occurring gut hormone may offer a long-term therapeutic approach to weight control. Here, the therapeutic potential of PYY is considered.Keywords
This publication has 30 references indexed in Scilit:
- Peptide YY(3–36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Peptide YY Directly Inhibits Ghrelin-Activated Neurons of the Arcuate Nucleus and Reverses Fasting-Induced c-Fos ExpressionNeuroendocrinology, 2004
- Enhancement of feeding suppression by PYY3-36 in rats with area postrema ablationsPeptides, 2004
- Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass SurgeryNew England Journal of Medicine, 2002
- Long-term Follow-up of Patients' Status after Gastric BypassObesity Surgery, 2001
- Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesityInternational Journal of Obesity, 1997
- Neuropeptide Y Family of Hormones: Receptor Subtypes and AntagonistsPeptides, 1997
- Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptideRegulatory Peptides, 1996
- Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior.Proceedings of the National Academy of Sciences, 1985
- Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptidesNature, 1980